CompletedNot Applicable

New Generation IGRA in Immunocompromised Individuals

Denmark, Germany, Italy2,663 participantsStarted 2015-12

Plain-language summary

Evaluation of a new ELISA based interferon-gamma release assay (QuantiFERON TB plus In-tube test) in immunocompromized patients

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Individuals as specified for the study Population * Written informed consent Exclusion Criteria: * \<18 years of age

Specificity

Timeframe: 2 years

Sensitivity

Timeframe: 2 years

Indeterminate results

Timeframe: 2 years

Association with exposure

Timeframe: 2 years

Progression

Timeframe: 4 years

NCT IDNCT02639936

SponsorTuberculosis Network European Trialsgroup

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2023-12